AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Vildagliptin in Nigeria
8 products registered with NAFDAC — 8 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Gliptus 50 mg Tablets_ Tablet | B4-9402 | EVA SCIENCES NIGERIA LIMITED | active | 26 Aug 2030 |
| Vildishal 50 Tablets Tablet | A4-100689 | Shalina Healthcare Nigeria Limited | active | 20 Dec 2028 |
| Vilget 50 mg Tablet Tablet | B4-9698 | Getz Pharma Nigeria Limited | active | 20 Dec 2028 |
| Galvus 50 mg Tablets** Tablet | A4-5369 | Novartis Nigeria Limited | active | 29 Nov 2028 |
| Xyvida Vildagliptin 50 mg Tablets Tablet | A4-100396 | Generix Global Investment Limited | active | 24 May 2028 |
| Vildagliptin Tablet 50 mg Tablet | B4-7681 | Novartis Nigeria Limited | active | 24 May 2028 |
| Wilcreas 50 Tablets Tablet | A4-100060 | Micro Nova Pharmaceuticals Ind Ltd | active | 27 May 2026 |
| Glipvas 50 Tablets Tablet | A4-100054 | Excel Charis Pharmaceutical Chemical Limited | active | 27 May 2026 |
Vildagliptin — NAFDAC Registration Details
NAFDAC (Nigeria) has 8 registered products containing Vildagliptin, of which 8 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Vildagliptin registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.